BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 967387)

  • 1. Prostaglandin E2 induction of labor for fetal demise.
    Kent DR; Goldstein AI
    Obstet Gynecol; 1976 Oct; 48(4):475-8. PubMed ID: 967387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of vaginal prostaglandin E2 suppositories in the management of third-trimester fetal demise.
    Kent DR; Goldstein AI; Linzey EM
    J Reprod Med; 1984 Feb; 29(2):101-2. PubMed ID: 6584630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of extrauterine fetal death with failure of prostaglandin E2 suppositories.
    Orr JW; Huddleston JF; Goldenberg RL; Knox GE; Davis RO
    Obstet Gynecol; 1979 Mar; 53(3 Suppl):56S-58S. PubMed ID: 424129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of intrauterine fetal demise and missed abortion using prostaglandin E2 vaginal suppositories.
    Southern EM; Gutknecht GD
    Obstet Gynecol; 1976 May; 47(5):602-6. PubMed ID: 1264407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral prostaglandin E2 and amniotomy for induction of labor.
    Craft I
    Adv Biosci; 1973; 9():593-8. PubMed ID: 4805874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of labor with prostaglandin E2 vaginal suppositories.
    Macer J; Buchanan D; Yonekura ML
    Obstet Gynecol; 1984 May; 63(5):664-8. PubMed ID: 6585734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin vaginal suppositories: a simple and safe approach to the induction of labor.
    Shepherd JH; Bennett MJ; Laurence D; Moore F; Sims CD
    Obstet Gynecol; 1981 Nov; 58(5):596-600. PubMed ID: 6946350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of labor in patients with missed abortion and fetal death in utero with protaglandin E2 suppositories.
    Lauersen NH; Wilson KH
    Am J Obstet Gynecol; 1977 Mar; 127(6):609-11. PubMed ID: 557289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of maternal side effects from prostaglandins used for cervical ripening.
    Goodlin RC; Reschl L; Clewell WH
    J Reprod Med; 1986 Dec; 31(12):1095-7. PubMed ID: 3467066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction of labor after intrauterine fetal death: A comparison between prostaglandin E2 and oxytocin.
    Gordon H; Pipe NG
    Obstet Gynecol; 1975 Jan; 45(1):44-6. PubMed ID: 1110817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral prostaglandin E2 for induction of labour at term.
    Campos G; Liggins GC
    N Z Med J; 1979 Oct; 90(646):326-7. PubMed ID: 293542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rare obstetric contraindication to the use of vaginal prostaglandins for fetal demise.
    Waszak SJ
    J Reprod Med; 1979 Apr; 22(4):204-6. PubMed ID: 458763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intravenous administration of prostaglandin F2alpha or prostaglandin E2 in labor pain induction in fetal death].
    Klausch B; Kruse HJ; Junge WD; Göretzlehner G
    Zentralbl Gynakol; 1974 Nov; 96(48):1505-13. PubMed ID: 4458350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of missed abortion and fetal death in utero.
    el-Damarawy H; el-Sahwi S; Toppozada M
    Prostaglandins; 1977 Sep; 14(3):583-90. PubMed ID: 905580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Induction of labor. A double-blind randomized study of prostaglandin E2 vaginal suppositories compared with intranasal oxytocin].
    Larsen J; Andreasson B; Bock JE
    Ugeskr Laeger; 1983 Aug; 145(34):2588-90. PubMed ID: 6351397
    [No Abstract]   [Full Text] [Related]  

  • 16. Cervical ripening with prostaglandin E2 vaginal suppositories.
    Buchanan D; Macer J; Yonekura ML
    Obstet Gynecol; 1984 May; 63(5):659-63. PubMed ID: 6585733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Third-trimester uterine rupture after prostaglandin E2 use for labor induction.
    Maymon R; Haimovich L; Shulman A; Pomeranz M; Holtzinger M; Bahary C
    J Reprod Med; 1992 May; 37(5):449-52. PubMed ID: 1507193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of intrauterine fetal death with prostaglandin E2 vaginal suppositories.
    Lauersen NH; Cederqvist LL; Wilson KH
    Am J Obstet Gynecol; 1980 Aug; 137(7):753-7. PubMed ID: 7405965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uterine hyperstimulation resulting from intravaginal prostaglandin E2. A case report.
    Chamberlin RO; Cohen GR; Knuppel RA
    J Reprod Med; 1987 Mar; 32(3):233-5. PubMed ID: 3471969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Labor induction in intrauterine fetal death].
    Butterwegge M; Gethmann U; Ohlenroth G
    Zentralbl Gynakol; 1990; 112(21):1335-9. PubMed ID: 2278217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.